In October 2025, NAL-NL3 was presented at the European Union of Hearing Aid Acousticians Congress in Germany, one of the world’s leading events for hearing care professionals and innovators. The presentation, delivered by Brent Edwards and Padraig Kitterick, was very well received, generating strong interest and positive feedback from clinicians, researchers, and industry partners. Attendees highlighted the significance of NAL-NL3 as an important advancement in evidence-based hearing aid prescription.